Surrogate end points and FDA approval: a tale of 2 lipid-altering drugs. [electronic resource]
Producer: 20080328Description: 1474-6 p. digitalISSN:- 1538-3598
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.